Showing posts with label Credit. Show all posts
Showing posts with label Credit. Show all posts

Monday, January 20, 2014

Citibank: Make the Citi Health credit card terms fair

English: First 4 digits of a credit card
 (Photo credit: Wikipedia)
The Citi Health Card -- a medical credit card from Citibank -- is one of the sneakiest credit products on the market today. The product includes "deferred interest" and a 30% interest rate. What this means is that after an introductory rate of 18 months, even after paying the minimum payment (or more) for the entire 18-mo period, the debtor incurs a finance charge for the 30% against the original balance.

I had an original debt of $4,000 that I had paid down to $2,881 over the 18 month introductory term of the Citi Health credit card. On the 19th month, after making payments every month, I was saddled with an additional $1954 debt due to the sneaky "deferred interest" clause.

Consumers are often signing up for this card when they have no other way to pay for out-of-pocket medical and dental costs. Worse still is that these products are exempt from federal truth-in-lending requirements, meaning that the medical professional doesn't even have to understand or explain the terms of the credit card to the consumer.

People trust their doctors and dentists and when they're told they need to buy a service (for example, corrective braces to prevent teeth from striking together which would ultimately cause teeth to fall out). When their medical professional tells them there's a debt product that can help them afford the procedure/product, they trust that their doctor wouldn't lead them into a trap.

A 30% interest rate is absurd for someone who pays their minimum payment on time and the whole idea of retroactive, deferred interest is sneaky at best. Citbank needs to stop tricking customers; they should:

- reduce the interest rate to a standard calculation (Prime + a rate based on user's credit score or debt-to-income ratio);

- adhere to the Truth in Lending Act (including use of Schumer box to make clear the interest rates being charged); and

- remove deferred interest features (interest can only be charged on the balance at end of promotional period, not original balance, and can only be charged on a go-forward basis, not retroactively)

Let's send a message to Citibank that consumers have enough to worry about without being tricked into these poisonous debt products.

By Ian Miller

Sent to us through Change.org's website.  

Enhanced by Zemanta

Saturday, July 20, 2013

Moody’s Upgrades Virginia Aaa Credit Rating Outlook to “Stable”

English: The state seal of Virginia. Српски / ...
English: The state seal of Virginia. Српски / Srpski: Застава америчке савезне државе Вирџиније. (Photo credit: Wikipedia)
Was Previously Reduced to “Negative” Following Federal Financial Troubles in 2011
**Moody’s Report Attached**

RICHMOND- Moody’s Investor Services has upgraded Virginia’s Aaa credit rating outlook from “negative”, which was assigned in August 2011, to “stable.” Virginia joins Maryland, Missouri and New Mexico in gaining an upgraded credit rating outlook. The four states were upgraded due to yesterday’s announcement that Moody’s had upgraded the federal credit rating outlook to “stable” as well.

In the release, which is attached, Moody’s notes:

“When Moody's placed the US government on negative outlook in 2011, it revised the outlooks of certain Aaa-rated US municipal issuers to negative to reflect their close economic, financial and capital markets linkages to the federal government. At the time, Moody’s indicated that if the US government rating were to move down, these ratings would also be likely to change because of their economic sensitivity to federal spending cuts, dependence on federal transfers and exposure to a capital markets disruption. The conditions that led to the return to a stable outlook on the US government rating reduce the exposure to these risks over Moody'’ outlook period. However, future federal budget and deficit actions could affect the credit quality of specific issuers independent of the US government bond rating or outlook.”
Enhanced by Zemanta